New Stock News | Xintai (002294.SZ) Hong Kong Stock IPO Prospectus Invalidated

Zhitong Caijing APP learned that Shenzhen Xintai Pharmaceutical Co., Ltd. (abbreviated as Xintai, 002294.SZ) submitted its Hong Kong IPO prospectus on February 12, 2026, which will expire on August 12, 2026, six months after submission. Goldman Sachs, Citigroup, and CITIC Securities are its joint sponsors at the time of filing.